NDC properties for "lenalidomide 25 MG Oral Capsule" (RxCUI 643720)
About this data
The tables show NDC propoerties for lenalidomide 25 MG Oral Capsule with the RxCUI 643720
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for lenalidomide 25 MG Oral Capsule (RxCUI 643720)
ANDA | ANDA201452 |
---|---|
ANDA | ANDA209348 |
ANDA | ANDA210154 |
ANDA | ANDA210435 |
ANDA | ANDA210480 |
ANDA | ANDA211022 |
ANDA | ANDA211846 |
ANDA | ANDA212414 |
ANDA | ANDA213885 |
ANDA | ANDA213912 |
MMSL_CODE | BD16978 |
MMSL_CODE | CD16978 |
RxCUI | 643720 |
SNOMEDCT | 840662000 |
SPL_SET_ID | 1b2716cf-24b4-4157-a218-58ede63917bd |
SPL_SET_ID | 51bfdd53-8fd9-4f86-bebe-75de29e6379d |
SPL_SET_ID | 682e8a86-9f49-45db-a2ea-403ee1dc62d2 |
SPL_SET_ID | 76f6c1e7-985b-43d9-892c-849df50ae80e |
SPL_SET_ID | 84d9dec7-9250-4dbd-9a0d-23e75f111892 |
SPL_SET_ID | 9943e098-20b0-dbb3-af12-7816eedd3f70 |
SPL_SET_ID | adee5af1-c9ab-c0c7-e400-dea7d2a0d4be |
SPL_SET_ID | ba2a07fd-ca60-40bc-b79b-9caf81900fa3 |
SPL_SET_ID | c98fb504-76d0-4c25-9c0b-412885828a7a |
SPL_SET_ID | ca8cc2cc-c856-e676-4f60-1e46d7b53d73 |
SPL_SET_ID | f27092f3-3977-4f4a-b214-45309e136e46 |
SPL_SET_ID | fd23328f-b019-4c14-80d9-4ebd997f26b2 |
VUID | 4025613 |
Prescribable Synonym | lenalidomide 25 MG Oral Capsule |
RXNAV_STR | lenalidomide 25 MG Oral Capsule |
RxNorm Name | lenalidomide 25 MG Oral Capsule |
Related queries | Interactions (for RxCUI 643720) |
NDC Properties
NDC Item 00378194001
NDC 9 | 0378-1940 |
---|---|
NDC 10 | 0378-1940-01 |
NDC Item | 00378194001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
ANDA | ANDA213912 |
COLORTEXT | WHITE(white opaque) |
Color | C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;25 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
NDC 9 | 0378-1940 |
---|---|
NDC 10 | 0378-1940-21 |
NDC Item | 00378194021 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
ANDA | ANDA213912 |
COLORTEXT | WHITE(white opaque) |
Color | C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;25 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
NDC 9 | 0480-1246 |
---|---|
NDC 10 | 0480-1246-21 |
NDC Item | 00480124621 |
Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
ANDA | ANDA201452 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 644159 |
Imprint code | NAT;25mg |
Labeler | Teva Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-03-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
NDC 9 | 31722-262 |
---|---|
NDC 10 | 31722-262-01 |
NDC Item | 31722026201 |
Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
ANDA | ANDA212414 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L7 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
NDC 9 | 31722-262 |
---|---|
NDC 10 | 31722-262-21 |
NDC Item | 31722026221 |
Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
ANDA | ANDA212414 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L7 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
NDC 9 | 43598-515 |
---|---|
NDC 10 | 43598-515-01 |
NDC Item | 43598051501 |
Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
ANDA | ANDA209348 |
COLORTEXT | WHITE(opaque white colored cap and body) |
Color | C48325 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;25;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
NDC 9 | 43598-515 |
---|---|
NDC 10 | 43598-515-21 |
NDC Item | 43598051521 |
Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
ANDA | ANDA209348 |
COLORTEXT | WHITE(opaque white colored cap and body) |
Color | C48325 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;25;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
NDC 9 | 47781-488 |
---|---|
NDC 10 | 47781-488-01 |
NDC Item | 47781048801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
ANDA | ANDA210480 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 789803 |
Imprint code | LP;642 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
NDC 9 | 47781-488 |
---|---|
NDC 10 | 47781-488-77 |
NDC Item | 47781048877 |
Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
ANDA | ANDA210480 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 789803 |
Imprint code | LP;642 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-01 |
NDC Item | 59651034701 |
Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-07 |
NDC Item | 59651034707 |
Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-21 |
NDC Item | 59651034721 |
Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 60505453701
NDC 9 | 60505-4537 |
---|---|
NDC 10 | 60505-4537-1 |
NDC Item | 60505453701 |
Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
Color | C48325;C48325 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L25 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
NDC 9 | 60505-4537 |
---|---|
NDC 10 | 60505-4537-2 |
NDC Item | 60505453702 |
Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
Color | C48325;C48325 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L25 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
NDC 9 | 63304-046 |
---|---|
NDC 10 | 63304-046-01 |
NDC Item | 63304004601 |
Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
ANDA | ANDA211846 |
COLORTEXT | WHITE,WHITE |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;83 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-04 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
NDC 9 | 63304-046 |
---|---|
NDC 10 | 63304-046-22 |
NDC Item | 63304004622 |
Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
ANDA | ANDA211846 |
COLORTEXT | WHITE,WHITE |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;83 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-04 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
NDC 9 | 69097-385 |
---|---|
NDC 10 | 69097-385-81 |
NDC Item | 69097038581 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
ANDA | ANDA210435 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 698711 |
Imprint code | Cipla25mg;385 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 69097-385 |
NDC Item 70710103501
NDC 9 | 70710-1035 |
---|---|
NDC 10 | 70710-1035-1 |
NDC Item | 70710103501 |
Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1035 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
NDC 9 | 70710-1035 |
---|---|
NDC 10 | 70710-1035-8 |
NDC Item | 70710103508 |
Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1035 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
NDC 9 | 70771-1681 |
---|---|
NDC 10 | 70771-1681-1 |
NDC Item | 70771168101 |
Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 800438 |
Imprint code | 1035 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
NDC 9 | 70771-1681 |
---|---|
NDC 10 | 70771-1681-8 |
NDC Item | 70771168108 |
Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 800438 |
Imprint code | 1035 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
NDC 9 | 76282-701 |
---|---|
NDC 10 | 76282-701-47 |
NDC Item | 76282070147 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
ANDA | ANDA210435 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 655779 |
Imprint code | Cipla25mg;385 |
Labeler | EXELAN PHARMACEUTICALS INC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 76282-701 |
NDC Item 00378194001
NDC 9 | 0378-1940 |
---|---|
NDC 10 | 0378-1940-01 |
NDC Item | 00378194001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
ANDA | ANDA213912 |
COLORTEXT | WHITE(white opaque) |
Color | C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;25 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
NDC 9 | 0378-1940 |
---|---|
NDC 10 | 0378-1940-21 |
NDC Item | 00378194021 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
ANDA | ANDA213912 |
COLORTEXT | WHITE(white opaque) |
Color | C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;25 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
NDC 9 | 0480-1246 |
---|---|
NDC 10 | 0480-1246-21 |
NDC Item | 00480124621 |
Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
ANDA | ANDA201452 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 644159 |
Imprint code | NAT;25mg |
Labeler | Teva Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-03-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
NDC 9 | 31722-262 |
---|---|
NDC 10 | 31722-262-01 |
NDC Item | 31722026201 |
Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
ANDA | ANDA212414 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L7 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
NDC 9 | 31722-262 |
---|---|
NDC 10 | 31722-262-21 |
NDC Item | 31722026221 |
Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
ANDA | ANDA212414 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L7 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
NDC 9 | 43598-515 |
---|---|
NDC 10 | 43598-515-01 |
NDC Item | 43598051501 |
Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
ANDA | ANDA209348 |
COLORTEXT | WHITE(opaque white colored cap and body) |
Color | C48325 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;25;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
NDC 9 | 43598-515 |
---|---|
NDC 10 | 43598-515-21 |
NDC Item | 43598051521 |
Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
ANDA | ANDA209348 |
COLORTEXT | WHITE(opaque white colored cap and body) |
Color | C48325 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;25;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
NDC 9 | 47781-488 |
---|---|
NDC 10 | 47781-488-01 |
NDC Item | 47781048801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
ANDA | ANDA210480 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 789803 |
Imprint code | LP;642 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
NDC 9 | 47781-488 |
---|---|
NDC 10 | 47781-488-77 |
NDC Item | 47781048877 |
Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
ANDA | ANDA210480 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 789803 |
Imprint code | LP;642 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-01 |
NDC Item | 59651034701 |
Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-07 |
NDC Item | 59651034707 |
Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-21 |
NDC Item | 59651034721 |
Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 60505453701
NDC 9 | 60505-4537 |
---|---|
NDC 10 | 60505-4537-1 |
NDC Item | 60505453701 |
Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
Color | C48325;C48325 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L25 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
NDC 9 | 60505-4537 |
---|---|
NDC 10 | 60505-4537-2 |
NDC Item | 60505453702 |
Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
Color | C48325;C48325 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L25 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
NDC 9 | 63304-046 |
---|---|
NDC 10 | 63304-046-01 |
NDC Item | 63304004601 |
Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
ANDA | ANDA211846 |
COLORTEXT | WHITE,WHITE |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;83 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-04 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
NDC 9 | 63304-046 |
---|---|
NDC 10 | 63304-046-22 |
NDC Item | 63304004622 |
Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
ANDA | ANDA211846 |
COLORTEXT | WHITE,WHITE |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;83 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-04 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
NDC 9 | 69097-385 |
---|---|
NDC 10 | 69097-385-81 |
NDC Item | 69097038581 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
ANDA | ANDA210435 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 698711 |
Imprint code | Cipla25mg;385 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 69097-385 |
NDC Item 70710103501
NDC 9 | 70710-1035 |
---|---|
NDC 10 | 70710-1035-1 |
NDC Item | 70710103501 |
Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1035 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
NDC 9 | 70710-1035 |
---|---|
NDC 10 | 70710-1035-8 |
NDC Item | 70710103508 |
Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1035 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
NDC 9 | 70771-1681 |
---|---|
NDC 10 | 70771-1681-1 |
NDC Item | 70771168101 |
Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 800438 |
Imprint code | 1035 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
NDC 9 | 70771-1681 |
---|---|
NDC 10 | 70771-1681-8 |
NDC Item | 70771168108 |
Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 800438 |
Imprint code | 1035 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
NDC 9 | 76282-701 |
---|---|
NDC 10 | 76282-701-47 |
NDC Item | 76282070147 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
ANDA | ANDA210435 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 655779 |
Imprint code | Cipla25mg;385 |
Labeler | EXELAN PHARMACEUTICALS INC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 76282-701 |
NDC Item 00378194001
NDC 9 | 0378-1940 |
---|---|
NDC 10 | 0378-1940-01 |
NDC Item | 00378194001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
ANDA | ANDA213912 |
COLORTEXT | WHITE(white opaque) |
Color | C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;25 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
NDC 9 | 0378-1940 |
---|---|
NDC 10 | 0378-1940-21 |
NDC Item | 00378194021 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
ANDA | ANDA213912 |
COLORTEXT | WHITE(white opaque) |
Color | C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;25 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
NDC 9 | 0480-1246 |
---|---|
NDC 10 | 0480-1246-21 |
NDC Item | 00480124621 |
Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
ANDA | ANDA201452 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 644159 |
Imprint code | NAT;25mg |
Labeler | Teva Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-03-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
NDC 9 | 31722-262 |
---|---|
NDC 10 | 31722-262-01 |
NDC Item | 31722026201 |
Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
ANDA | ANDA212414 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L7 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
NDC 9 | 31722-262 |
---|---|
NDC 10 | 31722-262-21 |
NDC Item | 31722026221 |
Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
ANDA | ANDA212414 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L7 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
NDC 9 | 43598-515 |
---|---|
NDC 10 | 43598-515-01 |
NDC Item | 43598051501 |
Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
ANDA | ANDA209348 |
COLORTEXT | WHITE(opaque white colored cap and body) |
Color | C48325 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;25;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
NDC 9 | 43598-515 |
---|---|
NDC 10 | 43598-515-21 |
NDC Item | 43598051521 |
Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
ANDA | ANDA209348 |
COLORTEXT | WHITE(opaque white colored cap and body) |
Color | C48325 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;25;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
NDC 9 | 47781-488 |
---|---|
NDC 10 | 47781-488-01 |
NDC Item | 47781048801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
ANDA | ANDA210480 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 789803 |
Imprint code | LP;642 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
NDC 9 | 47781-488 |
---|---|
NDC 10 | 47781-488-77 |
NDC Item | 47781048877 |
Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
ANDA | ANDA210480 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 789803 |
Imprint code | LP;642 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-01 |
NDC Item | 59651034701 |
Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-07 |
NDC Item | 59651034707 |
Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-21 |
NDC Item | 59651034721 |
Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 60505453701
NDC 9 | 60505-4537 |
---|---|
NDC 10 | 60505-4537-1 |
NDC Item | 60505453701 |
Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
Color | C48325;C48325 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L25 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
NDC 9 | 60505-4537 |
---|---|
NDC 10 | 60505-4537-2 |
NDC Item | 60505453702 |
Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
Color | C48325;C48325 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L25 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
NDC 9 | 63304-046 |
---|---|
NDC 10 | 63304-046-01 |
NDC Item | 63304004601 |
Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
ANDA | ANDA211846 |
COLORTEXT | WHITE,WHITE |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;83 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-04 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
NDC 9 | 63304-046 |
---|---|
NDC 10 | 63304-046-22 |
NDC Item | 63304004622 |
Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
ANDA | ANDA211846 |
COLORTEXT | WHITE,WHITE |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;83 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-04 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
NDC 9 | 69097-385 |
---|---|
NDC 10 | 69097-385-81 |
NDC Item | 69097038581 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
ANDA | ANDA210435 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 698711 |
Imprint code | Cipla25mg;385 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 69097-385 |
NDC Item 70710103501
NDC 9 | 70710-1035 |
---|---|
NDC 10 | 70710-1035-1 |
NDC Item | 70710103501 |
Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1035 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
NDC 9 | 70710-1035 |
---|---|
NDC 10 | 70710-1035-8 |
NDC Item | 70710103508 |
Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1035 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
NDC 9 | 70771-1681 |
---|---|
NDC 10 | 70771-1681-1 |
NDC Item | 70771168101 |
Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 800438 |
Imprint code | 1035 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
NDC 9 | 70771-1681 |
---|---|
NDC 10 | 70771-1681-8 |
NDC Item | 70771168108 |
Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 800438 |
Imprint code | 1035 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
NDC 9 | 76282-701 |
---|---|
NDC 10 | 76282-701-47 |
NDC Item | 76282070147 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
ANDA | ANDA210435 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 655779 |
Imprint code | Cipla25mg;385 |
Labeler | EXELAN PHARMACEUTICALS INC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 76282-701 |
NDC Item 00378194001
NDC 9 | 0378-1940 |
---|---|
NDC 10 | 0378-1940-01 |
NDC Item | 00378194001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
ANDA | ANDA213912 |
COLORTEXT | WHITE(white opaque) |
Color | C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;25 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
NDC 9 | 0378-1940 |
---|---|
NDC 10 | 0378-1940-21 |
NDC Item | 00378194021 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
ANDA | ANDA213912 |
COLORTEXT | WHITE(white opaque) |
Color | C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;25 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
NDC 9 | 0480-1246 |
---|---|
NDC 10 | 0480-1246-21 |
NDC Item | 00480124621 |
Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
ANDA | ANDA201452 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 644159 |
Imprint code | NAT;25mg |
Labeler | Teva Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-03-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
NDC 9 | 31722-262 |
---|---|
NDC 10 | 31722-262-01 |
NDC Item | 31722026201 |
Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
ANDA | ANDA212414 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L7 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
NDC 9 | 31722-262 |
---|---|
NDC 10 | 31722-262-21 |
NDC Item | 31722026221 |
Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
ANDA | ANDA212414 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L7 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
NDC 9 | 43598-515 |
---|---|
NDC 10 | 43598-515-01 |
NDC Item | 43598051501 |
Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
ANDA | ANDA209348 |
COLORTEXT | WHITE(opaque white colored cap and body) |
Color | C48325 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;25;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
NDC 9 | 43598-515 |
---|---|
NDC 10 | 43598-515-21 |
NDC Item | 43598051521 |
Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
ANDA | ANDA209348 |
COLORTEXT | WHITE(opaque white colored cap and body) |
Color | C48325 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;25;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
NDC 9 | 47781-488 |
---|---|
NDC 10 | 47781-488-01 |
NDC Item | 47781048801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
ANDA | ANDA210480 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 789803 |
Imprint code | LP;642 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
NDC 9 | 47781-488 |
---|---|
NDC 10 | 47781-488-77 |
NDC Item | 47781048877 |
Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
ANDA | ANDA210480 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 789803 |
Imprint code | LP;642 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-01 |
NDC Item | 59651034701 |
Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-07 |
NDC Item | 59651034707 |
Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-21 |
NDC Item | 59651034721 |
Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 60505453701
NDC 9 | 60505-4537 |
---|---|
NDC 10 | 60505-4537-1 |
NDC Item | 60505453701 |
Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
Color | C48325;C48325 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L25 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
NDC 9 | 60505-4537 |
---|---|
NDC 10 | 60505-4537-2 |
NDC Item | 60505453702 |
Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
Color | C48325;C48325 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L25 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
NDC 9 | 63304-046 |
---|---|
NDC 10 | 63304-046-01 |
NDC Item | 63304004601 |
Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
ANDA | ANDA211846 |
COLORTEXT | WHITE,WHITE |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;83 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-04 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
NDC 9 | 63304-046 |
---|---|
NDC 10 | 63304-046-22 |
NDC Item | 63304004622 |
Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
ANDA | ANDA211846 |
COLORTEXT | WHITE,WHITE |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;83 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-04 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
NDC 9 | 69097-385 |
---|---|
NDC 10 | 69097-385-81 |
NDC Item | 69097038581 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
ANDA | ANDA210435 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 698711 |
Imprint code | Cipla25mg;385 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 69097-385 |
NDC Item 70710103501
NDC 9 | 70710-1035 |
---|---|
NDC 10 | 70710-1035-1 |
NDC Item | 70710103501 |
Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1035 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
NDC 9 | 70710-1035 |
---|---|
NDC 10 | 70710-1035-8 |
NDC Item | 70710103508 |
Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1035 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
NDC 9 | 70771-1681 |
---|---|
NDC 10 | 70771-1681-1 |
NDC Item | 70771168101 |
Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 800438 |
Imprint code | 1035 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
NDC 9 | 70771-1681 |
---|---|
NDC 10 | 70771-1681-8 |
NDC Item | 70771168108 |
Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 800438 |
Imprint code | 1035 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
NDC 9 | 76282-701 |
---|---|
NDC 10 | 76282-701-47 |
NDC Item | 76282070147 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
ANDA | ANDA210435 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 655779 |
Imprint code | Cipla25mg;385 |
Labeler | EXELAN PHARMACEUTICALS INC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 76282-701 |
NDC Item 00378194001
NDC 9 | 0378-1940 |
---|---|
NDC 10 | 0378-1940-01 |
NDC Item | 00378194001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
ANDA | ANDA213912 |
COLORTEXT | WHITE(white opaque) |
Color | C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;25 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
NDC 9 | 0378-1940 |
---|---|
NDC 10 | 0378-1940-21 |
NDC Item | 00378194021 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
ANDA | ANDA213912 |
COLORTEXT | WHITE(white opaque) |
Color | C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;25 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
NDC 9 | 0480-1246 |
---|---|
NDC 10 | 0480-1246-21 |
NDC Item | 00480124621 |
Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
ANDA | ANDA201452 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 644159 |
Imprint code | NAT;25mg |
Labeler | Teva Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-03-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
NDC 9 | 31722-262 |
---|---|
NDC 10 | 31722-262-01 |
NDC Item | 31722026201 |
Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
ANDA | ANDA212414 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L7 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
NDC 9 | 31722-262 |
---|---|
NDC 10 | 31722-262-21 |
NDC Item | 31722026221 |
Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
ANDA | ANDA212414 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L7 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
NDC 9 | 43598-515 |
---|---|
NDC 10 | 43598-515-01 |
NDC Item | 43598051501 |
Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
ANDA | ANDA209348 |
COLORTEXT | WHITE(opaque white colored cap and body) |
Color | C48325 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;25;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
NDC 9 | 43598-515 |
---|---|
NDC 10 | 43598-515-21 |
NDC Item | 43598051521 |
Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
ANDA | ANDA209348 |
COLORTEXT | WHITE(opaque white colored cap and body) |
Color | C48325 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;25;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
NDC 9 | 47781-488 |
---|---|
NDC 10 | 47781-488-01 |
NDC Item | 47781048801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
ANDA | ANDA210480 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 789803 |
Imprint code | LP;642 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
NDC 9 | 47781-488 |
---|---|
NDC 10 | 47781-488-77 |
NDC Item | 47781048877 |
Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
ANDA | ANDA210480 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 789803 |
Imprint code | LP;642 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-01 |
NDC Item | 59651034701 |
Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-07 |
NDC Item | 59651034707 |
Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-21 |
NDC Item | 59651034721 |
Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 60505453701
NDC 9 | 60505-4537 |
---|---|
NDC 10 | 60505-4537-1 |
NDC Item | 60505453701 |
Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
Color | C48325;C48325 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L25 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
NDC 9 | 60505-4537 |
---|---|
NDC 10 | 60505-4537-2 |
NDC Item | 60505453702 |
Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
Color | C48325;C48325 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L25 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
NDC 9 | 63304-046 |
---|---|
NDC 10 | 63304-046-01 |
NDC Item | 63304004601 |
Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
ANDA | ANDA211846 |
COLORTEXT | WHITE,WHITE |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;83 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-04 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
NDC 9 | 63304-046 |
---|---|
NDC 10 | 63304-046-22 |
NDC Item | 63304004622 |
Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
ANDA | ANDA211846 |
COLORTEXT | WHITE,WHITE |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;83 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-04 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
NDC 9 | 69097-385 |
---|---|
NDC 10 | 69097-385-81 |
NDC Item | 69097038581 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
ANDA | ANDA210435 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 698711 |
Imprint code | Cipla25mg;385 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 69097-385 |
NDC Item 70710103501
NDC 9 | 70710-1035 |
---|---|
NDC 10 | 70710-1035-1 |
NDC Item | 70710103501 |
Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1035 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
NDC 9 | 70710-1035 |
---|---|
NDC 10 | 70710-1035-8 |
NDC Item | 70710103508 |
Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1035 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
NDC 9 | 70771-1681 |
---|---|
NDC 10 | 70771-1681-1 |
NDC Item | 70771168101 |
Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 800438 |
Imprint code | 1035 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
NDC 9 | 70771-1681 |
---|---|
NDC 10 | 70771-1681-8 |
NDC Item | 70771168108 |
Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 800438 |
Imprint code | 1035 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
NDC 9 | 76282-701 |
---|---|
NDC 10 | 76282-701-47 |
NDC Item | 76282070147 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
ANDA | ANDA210435 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 655779 |
Imprint code | Cipla25mg;385 |
Labeler | EXELAN PHARMACEUTICALS INC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 76282-701 |
NDC Item 00378194001
NDC 9 | 0378-1940 |
---|---|
NDC 10 | 0378-1940-01 |
NDC Item | 00378194001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
ANDA | ANDA213912 |
COLORTEXT | WHITE(white opaque) |
Color | C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;25 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
NDC 9 | 0378-1940 |
---|---|
NDC 10 | 0378-1940-21 |
NDC Item | 00378194021 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
ANDA | ANDA213912 |
COLORTEXT | WHITE(white opaque) |
Color | C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;25 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
NDC 9 | 0480-1246 |
---|---|
NDC 10 | 0480-1246-21 |
NDC Item | 00480124621 |
Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
ANDA | ANDA201452 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 644159 |
Imprint code | NAT;25mg |
Labeler | Teva Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-03-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
NDC 9 | 31722-262 |
---|---|
NDC 10 | 31722-262-01 |
NDC Item | 31722026201 |
Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
ANDA | ANDA212414 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L7 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
NDC 9 | 31722-262 |
---|---|
NDC 10 | 31722-262-21 |
NDC Item | 31722026221 |
Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
ANDA | ANDA212414 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L7 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
NDC 9 | 43598-515 |
---|---|
NDC 10 | 43598-515-01 |
NDC Item | 43598051501 |
Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
ANDA | ANDA209348 |
COLORTEXT | WHITE(opaque white colored cap and body) |
Color | C48325 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;25;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
NDC 9 | 43598-515 |
---|---|
NDC 10 | 43598-515-21 |
NDC Item | 43598051521 |
Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
ANDA | ANDA209348 |
COLORTEXT | WHITE(opaque white colored cap and body) |
Color | C48325 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;25;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
NDC 9 | 47781-488 |
---|---|
NDC 10 | 47781-488-01 |
NDC Item | 47781048801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
ANDA | ANDA210480 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 789803 |
Imprint code | LP;642 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
NDC 9 | 47781-488 |
---|---|
NDC 10 | 47781-488-77 |
NDC Item | 47781048877 |
Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
ANDA | ANDA210480 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 789803 |
Imprint code | LP;642 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-01 |
NDC Item | 59651034701 |
Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-07 |
NDC Item | 59651034707 |
Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-21 |
NDC Item | 59651034721 |
Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 60505453701
NDC 9 | 60505-4537 |
---|---|
NDC 10 | 60505-4537-1 |
NDC Item | 60505453701 |
Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
Color | C48325;C48325 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L25 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
NDC 9 | 60505-4537 |
---|---|
NDC 10 | 60505-4537-2 |
NDC Item | 60505453702 |
Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
Color | C48325;C48325 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L25 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
NDC 9 | 63304-046 |
---|---|
NDC 10 | 63304-046-01 |
NDC Item | 63304004601 |
Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
ANDA | ANDA211846 |
COLORTEXT | WHITE,WHITE |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;83 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-04 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
NDC 9 | 63304-046 |
---|---|
NDC 10 | 63304-046-22 |
NDC Item | 63304004622 |
Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
ANDA | ANDA211846 |
COLORTEXT | WHITE,WHITE |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;83 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-04 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
NDC 9 | 69097-385 |
---|---|
NDC 10 | 69097-385-81 |
NDC Item | 69097038581 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
ANDA | ANDA210435 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 698711 |
Imprint code | Cipla25mg;385 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 69097-385 |
NDC Item 70710103501
NDC 9 | 70710-1035 |
---|---|
NDC 10 | 70710-1035-1 |
NDC Item | 70710103501 |
Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1035 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
NDC 9 | 70710-1035 |
---|---|
NDC 10 | 70710-1035-8 |
NDC Item | 70710103508 |
Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1035 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
NDC 9 | 70771-1681 |
---|---|
NDC 10 | 70771-1681-1 |
NDC Item | 70771168101 |
Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 800438 |
Imprint code | 1035 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
NDC 9 | 70771-1681 |
---|---|
NDC 10 | 70771-1681-8 |
NDC Item | 70771168108 |
Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 800438 |
Imprint code | 1035 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
NDC 9 | 76282-701 |
---|---|
NDC 10 | 76282-701-47 |
NDC Item | 76282070147 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
ANDA | ANDA210435 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 655779 |
Imprint code | Cipla25mg;385 |
Labeler | EXELAN PHARMACEUTICALS INC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 76282-701 |
NDC Item 00378194001
NDC 9 | 0378-1940 |
---|---|
NDC 10 | 0378-1940-01 |
NDC Item | 00378194001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
ANDA | ANDA213912 |
COLORTEXT | WHITE(white opaque) |
Color | C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;25 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
NDC 9 | 0378-1940 |
---|---|
NDC 10 | 0378-1940-21 |
NDC Item | 00378194021 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
ANDA | ANDA213912 |
COLORTEXT | WHITE(white opaque) |
Color | C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;25 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
NDC 9 | 0480-1246 |
---|---|
NDC 10 | 0480-1246-21 |
NDC Item | 00480124621 |
Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
ANDA | ANDA201452 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 644159 |
Imprint code | NAT;25mg |
Labeler | Teva Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-03-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
NDC 9 | 31722-262 |
---|---|
NDC 10 | 31722-262-01 |
NDC Item | 31722026201 |
Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
ANDA | ANDA212414 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L7 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
NDC 9 | 31722-262 |
---|---|
NDC 10 | 31722-262-21 |
NDC Item | 31722026221 |
Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
ANDA | ANDA212414 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L7 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
NDC 9 | 43598-515 |
---|---|
NDC 10 | 43598-515-01 |
NDC Item | 43598051501 |
Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
ANDA | ANDA209348 |
COLORTEXT | WHITE(opaque white colored cap and body) |
Color | C48325 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;25;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
NDC 9 | 43598-515 |
---|---|
NDC 10 | 43598-515-21 |
NDC Item | 43598051521 |
Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
ANDA | ANDA209348 |
COLORTEXT | WHITE(opaque white colored cap and body) |
Color | C48325 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;25;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
NDC 9 | 47781-488 |
---|---|
NDC 10 | 47781-488-01 |
NDC Item | 47781048801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
ANDA | ANDA210480 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 789803 |
Imprint code | LP;642 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
NDC 9 | 47781-488 |
---|---|
NDC 10 | 47781-488-77 |
NDC Item | 47781048877 |
Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
ANDA | ANDA210480 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 789803 |
Imprint code | LP;642 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-01 |
NDC Item | 59651034701 |
Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-07 |
NDC Item | 59651034707 |
Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-21 |
NDC Item | 59651034721 |
Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 60505453701
NDC 9 | 60505-4537 |
---|---|
NDC 10 | 60505-4537-1 |
NDC Item | 60505453701 |
Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
Color | C48325;C48325 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L25 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
NDC 9 | 60505-4537 |
---|---|
NDC 10 | 60505-4537-2 |
NDC Item | 60505453702 |
Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
Color | C48325;C48325 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L25 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
NDC 9 | 63304-046 |
---|---|
NDC 10 | 63304-046-01 |
NDC Item | 63304004601 |
Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
ANDA | ANDA211846 |
COLORTEXT | WHITE,WHITE |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;83 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-04 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
NDC 9 | 63304-046 |
---|---|
NDC 10 | 63304-046-22 |
NDC Item | 63304004622 |
Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
ANDA | ANDA211846 |
COLORTEXT | WHITE,WHITE |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;83 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-04 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
NDC 9 | 69097-385 |
---|---|
NDC 10 | 69097-385-81 |
NDC Item | 69097038581 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
ANDA | ANDA210435 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 698711 |
Imprint code | Cipla25mg;385 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 69097-385 |
NDC Item 70710103501
NDC 9 | 70710-1035 |
---|---|
NDC 10 | 70710-1035-1 |
NDC Item | 70710103501 |
Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1035 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
NDC 9 | 70710-1035 |
---|---|
NDC 10 | 70710-1035-8 |
NDC Item | 70710103508 |
Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1035 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
NDC 9 | 70771-1681 |
---|---|
NDC 10 | 70771-1681-1 |
NDC Item | 70771168101 |
Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 800438 |
Imprint code | 1035 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
NDC 9 | 70771-1681 |
---|---|
NDC 10 | 70771-1681-8 |
NDC Item | 70771168108 |
Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 800438 |
Imprint code | 1035 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
NDC 9 | 76282-701 |
---|---|
NDC 10 | 76282-701-47 |
NDC Item | 76282070147 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
ANDA | ANDA210435 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 655779 |
Imprint code | Cipla25mg;385 |
Labeler | EXELAN PHARMACEUTICALS INC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 76282-701 |
NDC Item 00378194001
NDC 9 | 0378-1940 |
---|---|
NDC 10 | 0378-1940-01 |
NDC Item | 00378194001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
ANDA | ANDA213912 |
COLORTEXT | WHITE(white opaque) |
Color | C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;25 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
NDC 9 | 0378-1940 |
---|---|
NDC 10 | 0378-1940-21 |
NDC Item | 00378194021 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
ANDA | ANDA213912 |
COLORTEXT | WHITE(white opaque) |
Color | C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;25 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
NDC 9 | 0480-1246 |
---|---|
NDC 10 | 0480-1246-21 |
NDC Item | 00480124621 |
Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
ANDA | ANDA201452 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 644159 |
Imprint code | NAT;25mg |
Labeler | Teva Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-03-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
NDC 9 | 31722-262 |
---|---|
NDC 10 | 31722-262-01 |
NDC Item | 31722026201 |
Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
ANDA | ANDA212414 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L7 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
NDC 9 | 31722-262 |
---|---|
NDC 10 | 31722-262-21 |
NDC Item | 31722026221 |
Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
ANDA | ANDA212414 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L7 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
NDC 9 | 43598-515 |
---|---|
NDC 10 | 43598-515-01 |
NDC Item | 43598051501 |
Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
ANDA | ANDA209348 |
COLORTEXT | WHITE(opaque white colored cap and body) |
Color | C48325 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;25;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
NDC 9 | 43598-515 |
---|---|
NDC 10 | 43598-515-21 |
NDC Item | 43598051521 |
Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
ANDA | ANDA209348 |
COLORTEXT | WHITE(opaque white colored cap and body) |
Color | C48325 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;25;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
NDC 9 | 47781-488 |
---|---|
NDC 10 | 47781-488-01 |
NDC Item | 47781048801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
ANDA | ANDA210480 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 789803 |
Imprint code | LP;642 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
NDC 9 | 47781-488 |
---|---|
NDC 10 | 47781-488-77 |
NDC Item | 47781048877 |
Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
ANDA | ANDA210480 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 789803 |
Imprint code | LP;642 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-01 |
NDC Item | 59651034701 |
Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-07 |
NDC Item | 59651034707 |
Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-21 |
NDC Item | 59651034721 |
Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 60505453701
NDC 9 | 60505-4537 |
---|---|
NDC 10 | 60505-4537-1 |
NDC Item | 60505453701 |
Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
Color | C48325;C48325 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L25 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
NDC 9 | 60505-4537 |
---|---|
NDC 10 | 60505-4537-2 |
NDC Item | 60505453702 |
Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
Color | C48325;C48325 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L25 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
NDC 9 | 63304-046 |
---|---|
NDC 10 | 63304-046-01 |
NDC Item | 63304004601 |
Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
ANDA | ANDA211846 |
COLORTEXT | WHITE,WHITE |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;83 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-04 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
NDC 9 | 63304-046 |
---|---|
NDC 10 | 63304-046-22 |
NDC Item | 63304004622 |
Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
ANDA | ANDA211846 |
COLORTEXT | WHITE,WHITE |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;83 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-04 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
NDC 9 | 69097-385 |
---|---|
NDC 10 | 69097-385-81 |
NDC Item | 69097038581 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
ANDA | ANDA210435 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 698711 |
Imprint code | Cipla25mg;385 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 69097-385 |
NDC Item 70710103501
NDC 9 | 70710-1035 |
---|---|
NDC 10 | 70710-1035-1 |
NDC Item | 70710103501 |
Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1035 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
NDC 9 | 70710-1035 |
---|---|
NDC 10 | 70710-1035-8 |
NDC Item | 70710103508 |
Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1035 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
NDC 9 | 70771-1681 |
---|---|
NDC 10 | 70771-1681-1 |
NDC Item | 70771168101 |
Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 800438 |
Imprint code | 1035 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
NDC 9 | 70771-1681 |
---|---|
NDC 10 | 70771-1681-8 |
NDC Item | 70771168108 |
Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 800438 |
Imprint code | 1035 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
NDC 9 | 76282-701 |
---|---|
NDC 10 | 76282-701-47 |
NDC Item | 76282070147 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
ANDA | ANDA210435 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 655779 |
Imprint code | Cipla25mg;385 |
Labeler | EXELAN PHARMACEUTICALS INC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 76282-701 |
NDC Item 00378194001
NDC 9 | 0378-1940 |
---|---|
NDC 10 | 0378-1940-01 |
NDC Item | 00378194001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
ANDA | ANDA213912 |
COLORTEXT | WHITE(white opaque) |
Color | C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;25 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
NDC 9 | 0378-1940 |
---|---|
NDC 10 | 0378-1940-21 |
NDC Item | 00378194021 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
ANDA | ANDA213912 |
COLORTEXT | WHITE(white opaque) |
Color | C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;25 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
NDC 9 | 0480-1246 |
---|---|
NDC 10 | 0480-1246-21 |
NDC Item | 00480124621 |
Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
ANDA | ANDA201452 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 644159 |
Imprint code | NAT;25mg |
Labeler | Teva Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-03-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
NDC 9 | 31722-262 |
---|---|
NDC 10 | 31722-262-01 |
NDC Item | 31722026201 |
Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
ANDA | ANDA212414 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L7 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
NDC 9 | 31722-262 |
---|---|
NDC 10 | 31722-262-21 |
NDC Item | 31722026221 |
Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
ANDA | ANDA212414 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L7 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
NDC 9 | 43598-515 |
---|---|
NDC 10 | 43598-515-01 |
NDC Item | 43598051501 |
Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
ANDA | ANDA209348 |
COLORTEXT | WHITE(opaque white colored cap and body) |
Color | C48325 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;25;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
NDC 9 | 43598-515 |
---|---|
NDC 10 | 43598-515-21 |
NDC Item | 43598051521 |
Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
ANDA | ANDA209348 |
COLORTEXT | WHITE(opaque white colored cap and body) |
Color | C48325 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;25;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
NDC 9 | 47781-488 |
---|---|
NDC 10 | 47781-488-01 |
NDC Item | 47781048801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
ANDA | ANDA210480 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 789803 |
Imprint code | LP;642 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
NDC 9 | 47781-488 |
---|---|
NDC 10 | 47781-488-77 |
NDC Item | 47781048877 |
Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
ANDA | ANDA210480 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 789803 |
Imprint code | LP;642 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-01 |
NDC Item | 59651034701 |
Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-07 |
NDC Item | 59651034707 |
Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-21 |
NDC Item | 59651034721 |
Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 60505453701
NDC 9 | 60505-4537 |
---|---|
NDC 10 | 60505-4537-1 |
NDC Item | 60505453701 |
Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
Color | C48325;C48325 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L25 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
NDC 9 | 60505-4537 |
---|---|
NDC 10 | 60505-4537-2 |
NDC Item | 60505453702 |
Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
Color | C48325;C48325 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L25 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
NDC 9 | 63304-046 |
---|---|
NDC 10 | 63304-046-01 |
NDC Item | 63304004601 |
Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
ANDA | ANDA211846 |
COLORTEXT | WHITE,WHITE |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;83 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-04 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
NDC 9 | 63304-046 |
---|---|
NDC 10 | 63304-046-22 |
NDC Item | 63304004622 |
Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
ANDA | ANDA211846 |
COLORTEXT | WHITE,WHITE |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;83 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-04 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
NDC 9 | 69097-385 |
---|---|
NDC 10 | 69097-385-81 |
NDC Item | 69097038581 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
ANDA | ANDA210435 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 698711 |
Imprint code | Cipla25mg;385 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 69097-385 |
NDC Item 70710103501
NDC 9 | 70710-1035 |
---|---|
NDC 10 | 70710-1035-1 |
NDC Item | 70710103501 |
Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1035 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
NDC 9 | 70710-1035 |
---|---|
NDC 10 | 70710-1035-8 |
NDC Item | 70710103508 |
Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1035 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
NDC 9 | 70771-1681 |
---|---|
NDC 10 | 70771-1681-1 |
NDC Item | 70771168101 |
Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 800438 |
Imprint code | 1035 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
NDC 9 | 70771-1681 |
---|---|
NDC 10 | 70771-1681-8 |
NDC Item | 70771168108 |
Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 800438 |
Imprint code | 1035 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
NDC 9 | 76282-701 |
---|---|
NDC 10 | 76282-701-47 |
NDC Item | 76282070147 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
ANDA | ANDA210435 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 655779 |
Imprint code | Cipla25mg;385 |
Labeler | EXELAN PHARMACEUTICALS INC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 76282-701 |
NDC Item 00378194001
NDC 9 | 0378-1940 |
---|---|
NDC 10 | 0378-1940-01 |
NDC Item | 00378194001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
ANDA | ANDA213912 |
COLORTEXT | WHITE(white opaque) |
Color | C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;25 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
NDC 9 | 0378-1940 |
---|---|
NDC 10 | 0378-1940-21 |
NDC Item | 00378194021 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
ANDA | ANDA213912 |
COLORTEXT | WHITE(white opaque) |
Color | C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;25 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
NDC 9 | 0480-1246 |
---|---|
NDC 10 | 0480-1246-21 |
NDC Item | 00480124621 |
Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
ANDA | ANDA201452 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 644159 |
Imprint code | NAT;25mg |
Labeler | Teva Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-03-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
NDC 9 | 31722-262 |
---|---|
NDC 10 | 31722-262-01 |
NDC Item | 31722026201 |
Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
ANDA | ANDA212414 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L7 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
NDC 9 | 31722-262 |
---|---|
NDC 10 | 31722-262-21 |
NDC Item | 31722026221 |
Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
ANDA | ANDA212414 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L7 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
NDC 9 | 43598-515 |
---|---|
NDC 10 | 43598-515-01 |
NDC Item | 43598051501 |
Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
ANDA | ANDA209348 |
COLORTEXT | WHITE(opaque white colored cap and body) |
Color | C48325 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;25;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
NDC 9 | 43598-515 |
---|---|
NDC 10 | 43598-515-21 |
NDC Item | 43598051521 |
Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
ANDA | ANDA209348 |
COLORTEXT | WHITE(opaque white colored cap and body) |
Color | C48325 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;25;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
NDC 9 | 47781-488 |
---|---|
NDC 10 | 47781-488-01 |
NDC Item | 47781048801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
ANDA | ANDA210480 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 789803 |
Imprint code | LP;642 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
NDC 9 | 47781-488 |
---|---|
NDC 10 | 47781-488-77 |
NDC Item | 47781048877 |
Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
ANDA | ANDA210480 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 789803 |
Imprint code | LP;642 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-01 |
NDC Item | 59651034701 |
Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-07 |
NDC Item | 59651034707 |
Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-21 |
NDC Item | 59651034721 |
Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 60505453701
NDC 9 | 60505-4537 |
---|---|
NDC 10 | 60505-4537-1 |
NDC Item | 60505453701 |
Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
Color | C48325;C48325 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L25 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
NDC 9 | 60505-4537 |
---|---|
NDC 10 | 60505-4537-2 |
NDC Item | 60505453702 |
Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
Color | C48325;C48325 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L25 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
NDC 9 | 63304-046 |
---|---|
NDC 10 | 63304-046-01 |
NDC Item | 63304004601 |
Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
ANDA | ANDA211846 |
COLORTEXT | WHITE,WHITE |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;83 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-04 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
NDC 9 | 63304-046 |
---|---|
NDC 10 | 63304-046-22 |
NDC Item | 63304004622 |
Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
ANDA | ANDA211846 |
COLORTEXT | WHITE,WHITE |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;83 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-04 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
NDC 9 | 69097-385 |
---|---|
NDC 10 | 69097-385-81 |
NDC Item | 69097038581 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
ANDA | ANDA210435 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 698711 |
Imprint code | Cipla25mg;385 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 69097-385 |
NDC Item 70710103501
NDC 9 | 70710-1035 |
---|---|
NDC 10 | 70710-1035-1 |
NDC Item | 70710103501 |
Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1035 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
NDC 9 | 70710-1035 |
---|---|
NDC 10 | 70710-1035-8 |
NDC Item | 70710103508 |
Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1035 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
NDC 9 | 70771-1681 |
---|---|
NDC 10 | 70771-1681-1 |
NDC Item | 70771168101 |
Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 800438 |
Imprint code | 1035 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
NDC 9 | 70771-1681 |
---|---|
NDC 10 | 70771-1681-8 |
NDC Item | 70771168108 |
Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 800438 |
Imprint code | 1035 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
NDC 9 | 76282-701 |
---|---|
NDC 10 | 76282-701-47 |
NDC Item | 76282070147 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
ANDA | ANDA210435 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 655779 |
Imprint code | Cipla25mg;385 |
Labeler | EXELAN PHARMACEUTICALS INC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 76282-701 |
NDC Item 00378194001
NDC 9 | 0378-1940 |
---|---|
NDC 10 | 0378-1940-01 |
NDC Item | 00378194001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
ANDA | ANDA213912 |
COLORTEXT | WHITE(white opaque) |
Color | C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;25 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
NDC 9 | 0378-1940 |
---|---|
NDC 10 | 0378-1940-21 |
NDC Item | 00378194021 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
ANDA | ANDA213912 |
COLORTEXT | WHITE(white opaque) |
Color | C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;25 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
NDC 9 | 0480-1246 |
---|---|
NDC 10 | 0480-1246-21 |
NDC Item | 00480124621 |
Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
ANDA | ANDA201452 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 644159 |
Imprint code | NAT;25mg |
Labeler | Teva Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-03-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
NDC 9 | 31722-262 |
---|---|
NDC 10 | 31722-262-01 |
NDC Item | 31722026201 |
Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
ANDA | ANDA212414 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L7 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
NDC 9 | 31722-262 |
---|---|
NDC 10 | 31722-262-21 |
NDC Item | 31722026221 |
Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
ANDA | ANDA212414 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L7 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
NDC 9 | 43598-515 |
---|---|
NDC 10 | 43598-515-01 |
NDC Item | 43598051501 |
Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
ANDA | ANDA209348 |
COLORTEXT | WHITE(opaque white colored cap and body) |
Color | C48325 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;25;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
NDC 9 | 43598-515 |
---|---|
NDC 10 | 43598-515-21 |
NDC Item | 43598051521 |
Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
ANDA | ANDA209348 |
COLORTEXT | WHITE(opaque white colored cap and body) |
Color | C48325 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;25;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
NDC 9 | 47781-488 |
---|---|
NDC 10 | 47781-488-01 |
NDC Item | 47781048801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
ANDA | ANDA210480 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 789803 |
Imprint code | LP;642 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
NDC 9 | 47781-488 |
---|---|
NDC 10 | 47781-488-77 |
NDC Item | 47781048877 |
Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
ANDA | ANDA210480 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 789803 |
Imprint code | LP;642 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-01 |
NDC Item | 59651034701 |
Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-07 |
NDC Item | 59651034707 |
Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-21 |
NDC Item | 59651034721 |
Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 60505453701
NDC 9 | 60505-4537 |
---|---|
NDC 10 | 60505-4537-1 |
NDC Item | 60505453701 |
Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
Color | C48325;C48325 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L25 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
NDC 9 | 60505-4537 |
---|---|
NDC 10 | 60505-4537-2 |
NDC Item | 60505453702 |
Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
Color | C48325;C48325 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L25 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
NDC 9 | 63304-046 |
---|---|
NDC 10 | 63304-046-01 |
NDC Item | 63304004601 |
Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
ANDA | ANDA211846 |
COLORTEXT | WHITE,WHITE |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;83 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-04 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
NDC 9 | 63304-046 |
---|---|
NDC 10 | 63304-046-22 |
NDC Item | 63304004622 |
Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
ANDA | ANDA211846 |
COLORTEXT | WHITE,WHITE |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;83 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-04 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
NDC 9 | 69097-385 |
---|---|
NDC 10 | 69097-385-81 |
NDC Item | 69097038581 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
ANDA | ANDA210435 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 698711 |
Imprint code | Cipla25mg;385 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 69097-385 |
NDC Item 70710103501
NDC 9 | 70710-1035 |
---|---|
NDC 10 | 70710-1035-1 |
NDC Item | 70710103501 |
Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1035 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
NDC 9 | 70710-1035 |
---|---|
NDC 10 | 70710-1035-8 |
NDC Item | 70710103508 |
Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1035 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
NDC 9 | 70771-1681 |
---|---|
NDC 10 | 70771-1681-1 |
NDC Item | 70771168101 |
Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 800438 |
Imprint code | 1035 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
NDC 9 | 70771-1681 |
---|---|
NDC 10 | 70771-1681-8 |
NDC Item | 70771168108 |
Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 800438 |
Imprint code | 1035 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
NDC 9 | 76282-701 |
---|---|
NDC 10 | 76282-701-47 |
NDC Item | 76282070147 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
ANDA | ANDA210435 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 655779 |
Imprint code | Cipla25mg;385 |
Labeler | EXELAN PHARMACEUTICALS INC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 76282-701 |
NDC Item 00378194001
NDC 9 | 0378-1940 |
---|---|
NDC 10 | 0378-1940-01 |
NDC Item | 00378194001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
ANDA | ANDA213912 |
COLORTEXT | WHITE(white opaque) |
Color | C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;25 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
NDC 9 | 0378-1940 |
---|---|
NDC 10 | 0378-1940-21 |
NDC Item | 00378194021 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
ANDA | ANDA213912 |
COLORTEXT | WHITE(white opaque) |
Color | C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;25 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
NDC 9 | 0480-1246 |
---|---|
NDC 10 | 0480-1246-21 |
NDC Item | 00480124621 |
Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
ANDA | ANDA201452 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 644159 |
Imprint code | NAT;25mg |
Labeler | Teva Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-03-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
NDC 9 | 31722-262 |
---|---|
NDC 10 | 31722-262-01 |
NDC Item | 31722026201 |
Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
ANDA | ANDA212414 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L7 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
NDC 9 | 31722-262 |
---|---|
NDC 10 | 31722-262-21 |
NDC Item | 31722026221 |
Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
ANDA | ANDA212414 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L7 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
NDC 9 | 43598-515 |
---|---|
NDC 10 | 43598-515-01 |
NDC Item | 43598051501 |
Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
ANDA | ANDA209348 |
COLORTEXT | WHITE(opaque white colored cap and body) |
Color | C48325 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;25;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
NDC 9 | 43598-515 |
---|---|
NDC 10 | 43598-515-21 |
NDC Item | 43598051521 |
Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
ANDA | ANDA209348 |
COLORTEXT | WHITE(opaque white colored cap and body) |
Color | C48325 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;25;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
NDC 9 | 47781-488 |
---|---|
NDC 10 | 47781-488-01 |
NDC Item | 47781048801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
ANDA | ANDA210480 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 789803 |
Imprint code | LP;642 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
NDC 9 | 47781-488 |
---|---|
NDC 10 | 47781-488-77 |
NDC Item | 47781048877 |
Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
ANDA | ANDA210480 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 789803 |
Imprint code | LP;642 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-01 |
NDC Item | 59651034701 |
Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-07 |
NDC Item | 59651034707 |
Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-21 |
NDC Item | 59651034721 |
Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 60505453701
NDC 9 | 60505-4537 |
---|---|
NDC 10 | 60505-4537-1 |
NDC Item | 60505453701 |
Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
Color | C48325;C48325 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L25 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
NDC 9 | 60505-4537 |
---|---|
NDC 10 | 60505-4537-2 |
NDC Item | 60505453702 |
Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
Color | C48325;C48325 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L25 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
NDC 9 | 63304-046 |
---|---|
NDC 10 | 63304-046-01 |
NDC Item | 63304004601 |
Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
ANDA | ANDA211846 |
COLORTEXT | WHITE,WHITE |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;83 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-04 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
NDC 9 | 63304-046 |
---|---|
NDC 10 | 63304-046-22 |
NDC Item | 63304004622 |
Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
ANDA | ANDA211846 |
COLORTEXT | WHITE,WHITE |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;83 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-04 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
NDC 9 | 69097-385 |
---|---|
NDC 10 | 69097-385-81 |
NDC Item | 69097038581 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
ANDA | ANDA210435 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 698711 |
Imprint code | Cipla25mg;385 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 69097-385 |
NDC Item 70710103501
NDC 9 | 70710-1035 |
---|---|
NDC 10 | 70710-1035-1 |
NDC Item | 70710103501 |
Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1035 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
NDC 9 | 70710-1035 |
---|---|
NDC 10 | 70710-1035-8 |
NDC Item | 70710103508 |
Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1035 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
NDC 9 | 70771-1681 |
---|---|
NDC 10 | 70771-1681-1 |
NDC Item | 70771168101 |
Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 800438 |
Imprint code | 1035 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
NDC 9 | 70771-1681 |
---|---|
NDC 10 | 70771-1681-8 |
NDC Item | 70771168108 |
Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 800438 |
Imprint code | 1035 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
NDC 9 | 76282-701 |
---|---|
NDC 10 | 76282-701-47 |
NDC Item | 76282070147 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
ANDA | ANDA210435 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 655779 |
Imprint code | Cipla25mg;385 |
Labeler | EXELAN PHARMACEUTICALS INC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 76282-701 |
NDC Item 00378194001
NDC 9 | 0378-1940 |
---|---|
NDC 10 | 0378-1940-01 |
NDC Item | 00378194001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
ANDA | ANDA213912 |
COLORTEXT | WHITE(white opaque) |
Color | C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;25 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
NDC 9 | 0378-1940 |
---|---|
NDC 10 | 0378-1940-21 |
NDC Item | 00378194021 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
ANDA | ANDA213912 |
COLORTEXT | WHITE(white opaque) |
Color | C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;25 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
NDC 9 | 0480-1246 |
---|---|
NDC 10 | 0480-1246-21 |
NDC Item | 00480124621 |
Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
ANDA | ANDA201452 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 644159 |
Imprint code | NAT;25mg |
Labeler | Teva Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-03-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
NDC 9 | 31722-262 |
---|---|
NDC 10 | 31722-262-01 |
NDC Item | 31722026201 |
Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
ANDA | ANDA212414 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L7 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
NDC 9 | 31722-262 |
---|---|
NDC 10 | 31722-262-21 |
NDC Item | 31722026221 |
Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
ANDA | ANDA212414 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L7 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
NDC 9 | 43598-515 |
---|---|
NDC 10 | 43598-515-01 |
NDC Item | 43598051501 |
Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
ANDA | ANDA209348 |
COLORTEXT | WHITE(opaque white colored cap and body) |
Color | C48325 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;25;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
NDC 9 | 43598-515 |
---|---|
NDC 10 | 43598-515-21 |
NDC Item | 43598051521 |
Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
ANDA | ANDA209348 |
COLORTEXT | WHITE(opaque white colored cap and body) |
Color | C48325 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;25;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
NDC 9 | 47781-488 |
---|---|
NDC 10 | 47781-488-01 |
NDC Item | 47781048801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
ANDA | ANDA210480 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 789803 |
Imprint code | LP;642 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
NDC 9 | 47781-488 |
---|---|
NDC 10 | 47781-488-77 |
NDC Item | 47781048877 |
Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
ANDA | ANDA210480 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 789803 |
Imprint code | LP;642 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-01 |
NDC Item | 59651034701 |
Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-07 |
NDC Item | 59651034707 |
Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-21 |
NDC Item | 59651034721 |
Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 60505453701
NDC 9 | 60505-4537 |
---|---|
NDC 10 | 60505-4537-1 |
NDC Item | 60505453701 |
Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
Color | C48325;C48325 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L25 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
NDC 9 | 60505-4537 |
---|---|
NDC 10 | 60505-4537-2 |
NDC Item | 60505453702 |
Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
Color | C48325;C48325 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L25 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
NDC 9 | 63304-046 |
---|---|
NDC 10 | 63304-046-01 |
NDC Item | 63304004601 |
Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
ANDA | ANDA211846 |
COLORTEXT | WHITE,WHITE |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;83 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-04 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
NDC 9 | 63304-046 |
---|---|
NDC 10 | 63304-046-22 |
NDC Item | 63304004622 |
Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
ANDA | ANDA211846 |
COLORTEXT | WHITE,WHITE |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;83 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-04 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
NDC 9 | 69097-385 |
---|---|
NDC 10 | 69097-385-81 |
NDC Item | 69097038581 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
ANDA | ANDA210435 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 698711 |
Imprint code | Cipla25mg;385 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 69097-385 |
NDC Item 70710103501
NDC 9 | 70710-1035 |
---|---|
NDC 10 | 70710-1035-1 |
NDC Item | 70710103501 |
Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1035 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
NDC 9 | 70710-1035 |
---|---|
NDC 10 | 70710-1035-8 |
NDC Item | 70710103508 |
Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1035 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
NDC 9 | 70771-1681 |
---|---|
NDC 10 | 70771-1681-1 |
NDC Item | 70771168101 |
Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 800438 |
Imprint code | 1035 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
NDC 9 | 70771-1681 |
---|---|
NDC 10 | 70771-1681-8 |
NDC Item | 70771168108 |
Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 800438 |
Imprint code | 1035 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
NDC 9 | 76282-701 |
---|---|
NDC 10 | 76282-701-47 |
NDC Item | 76282070147 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
ANDA | ANDA210435 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 655779 |
Imprint code | Cipla25mg;385 |
Labeler | EXELAN PHARMACEUTICALS INC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 76282-701 |
NDC Item 00378194001
NDC 9 | 0378-1940 |
---|---|
NDC 10 | 0378-1940-01 |
NDC Item | 00378194001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
ANDA | ANDA213912 |
COLORTEXT | WHITE(white opaque) |
Color | C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;25 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
NDC 9 | 0378-1940 |
---|---|
NDC 10 | 0378-1940-21 |
NDC Item | 00378194021 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
ANDA | ANDA213912 |
COLORTEXT | WHITE(white opaque) |
Color | C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;25 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
NDC 9 | 0480-1246 |
---|---|
NDC 10 | 0480-1246-21 |
NDC Item | 00480124621 |
Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
ANDA | ANDA201452 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 644159 |
Imprint code | NAT;25mg |
Labeler | Teva Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-03-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
NDC 9 | 31722-262 |
---|---|
NDC 10 | 31722-262-01 |
NDC Item | 31722026201 |
Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
ANDA | ANDA212414 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L7 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
NDC 9 | 31722-262 |
---|---|
NDC 10 | 31722-262-21 |
NDC Item | 31722026221 |
Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
ANDA | ANDA212414 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L7 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
NDC 9 | 43598-515 |
---|---|
NDC 10 | 43598-515-01 |
NDC Item | 43598051501 |
Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
ANDA | ANDA209348 |
COLORTEXT | WHITE(opaque white colored cap and body) |
Color | C48325 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;25;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
NDC 9 | 43598-515 |
---|---|
NDC 10 | 43598-515-21 |
NDC Item | 43598051521 |
Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
ANDA | ANDA209348 |
COLORTEXT | WHITE(opaque white colored cap and body) |
Color | C48325 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;25;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
NDC 9 | 47781-488 |
---|---|
NDC 10 | 47781-488-01 |
NDC Item | 47781048801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
ANDA | ANDA210480 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 789803 |
Imprint code | LP;642 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
NDC 9 | 47781-488 |
---|---|
NDC 10 | 47781-488-77 |
NDC Item | 47781048877 |
Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
ANDA | ANDA210480 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 789803 |
Imprint code | LP;642 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-01 |
NDC Item | 59651034701 |
Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-07 |
NDC Item | 59651034707 |
Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-21 |
NDC Item | 59651034721 |
Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 60505453701
NDC 9 | 60505-4537 |
---|---|
NDC 10 | 60505-4537-1 |
NDC Item | 60505453701 |
Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
Color | C48325;C48325 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L25 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
NDC 9 | 60505-4537 |
---|---|
NDC 10 | 60505-4537-2 |
NDC Item | 60505453702 |
Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
Color | C48325;C48325 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L25 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
NDC 9 | 63304-046 |
---|---|
NDC 10 | 63304-046-01 |
NDC Item | 63304004601 |
Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
ANDA | ANDA211846 |
COLORTEXT | WHITE,WHITE |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;83 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-04 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
NDC 9 | 63304-046 |
---|---|
NDC 10 | 63304-046-22 |
NDC Item | 63304004622 |
Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
ANDA | ANDA211846 |
COLORTEXT | WHITE,WHITE |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;83 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-04 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
NDC 9 | 69097-385 |
---|---|
NDC 10 | 69097-385-81 |
NDC Item | 69097038581 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
ANDA | ANDA210435 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 698711 |
Imprint code | Cipla25mg;385 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 69097-385 |
NDC Item 70710103501
NDC 9 | 70710-1035 |
---|---|
NDC 10 | 70710-1035-1 |
NDC Item | 70710103501 |
Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1035 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
NDC 9 | 70710-1035 |
---|---|
NDC 10 | 70710-1035-8 |
NDC Item | 70710103508 |
Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1035 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
NDC 9 | 70771-1681 |
---|---|
NDC 10 | 70771-1681-1 |
NDC Item | 70771168101 |
Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 800438 |
Imprint code | 1035 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
NDC 9 | 70771-1681 |
---|---|
NDC 10 | 70771-1681-8 |
NDC Item | 70771168108 |
Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 800438 |
Imprint code | 1035 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
NDC 9 | 76282-701 |
---|---|
NDC 10 | 76282-701-47 |
NDC Item | 76282070147 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
ANDA | ANDA210435 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 655779 |
Imprint code | Cipla25mg;385 |
Labeler | EXELAN PHARMACEUTICALS INC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 76282-701 |
NDC Item 00378194001
NDC 9 | 0378-1940 |
---|---|
NDC 10 | 0378-1940-01 |
NDC Item | 00378194001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
ANDA | ANDA213912 |
COLORTEXT | WHITE(white opaque) |
Color | C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;25 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
NDC 9 | 0378-1940 |
---|---|
NDC 10 | 0378-1940-21 |
NDC Item | 00378194021 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
ANDA | ANDA213912 |
COLORTEXT | WHITE(white opaque) |
Color | C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;25 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
NDC 9 | 0480-1246 |
---|---|
NDC 10 | 0480-1246-21 |
NDC Item | 00480124621 |
Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
ANDA | ANDA201452 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 644159 |
Imprint code | NAT;25mg |
Labeler | Teva Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-03-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
NDC 9 | 31722-262 |
---|---|
NDC 10 | 31722-262-01 |
NDC Item | 31722026201 |
Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
ANDA | ANDA212414 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L7 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
NDC 9 | 31722-262 |
---|---|
NDC 10 | 31722-262-21 |
NDC Item | 31722026221 |
Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
ANDA | ANDA212414 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L7 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
NDC 9 | 43598-515 |
---|---|
NDC 10 | 43598-515-01 |
NDC Item | 43598051501 |
Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
ANDA | ANDA209348 |
COLORTEXT | WHITE(opaque white colored cap and body) |
Color | C48325 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;25;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
NDC 9 | 43598-515 |
---|---|
NDC 10 | 43598-515-21 |
NDC Item | 43598051521 |
Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
ANDA | ANDA209348 |
COLORTEXT | WHITE(opaque white colored cap and body) |
Color | C48325 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;25;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
NDC 9 | 47781-488 |
---|---|
NDC 10 | 47781-488-01 |
NDC Item | 47781048801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
ANDA | ANDA210480 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 789803 |
Imprint code | LP;642 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
NDC 9 | 47781-488 |
---|---|
NDC 10 | 47781-488-77 |
NDC Item | 47781048877 |
Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
ANDA | ANDA210480 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 789803 |
Imprint code | LP;642 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-01 |
NDC Item | 59651034701 |
Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-07 |
NDC Item | 59651034707 |
Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-21 |
NDC Item | 59651034721 |
Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 60505453701
NDC 9 | 60505-4537 |
---|---|
NDC 10 | 60505-4537-1 |
NDC Item | 60505453701 |
Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
Color | C48325;C48325 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L25 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
NDC 9 | 60505-4537 |
---|---|
NDC 10 | 60505-4537-2 |
NDC Item | 60505453702 |
Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
Color | C48325;C48325 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L25 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
NDC 9 | 63304-046 |
---|---|
NDC 10 | 63304-046-01 |
NDC Item | 63304004601 |
Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
ANDA | ANDA211846 |
COLORTEXT | WHITE,WHITE |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;83 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-04 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
NDC 9 | 63304-046 |
---|---|
NDC 10 | 63304-046-22 |
NDC Item | 63304004622 |
Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
ANDA | ANDA211846 |
COLORTEXT | WHITE,WHITE |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;83 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-04 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
NDC 9 | 69097-385 |
---|---|
NDC 10 | 69097-385-81 |
NDC Item | 69097038581 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
ANDA | ANDA210435 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 698711 |
Imprint code | Cipla25mg;385 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 69097-385 |
NDC Item 70710103501
NDC 9 | 70710-1035 |
---|---|
NDC 10 | 70710-1035-1 |
NDC Item | 70710103501 |
Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1035 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
NDC 9 | 70710-1035 |
---|---|
NDC 10 | 70710-1035-8 |
NDC Item | 70710103508 |
Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1035 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
NDC 9 | 70771-1681 |
---|---|
NDC 10 | 70771-1681-1 |
NDC Item | 70771168101 |
Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 800438 |
Imprint code | 1035 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
NDC 9 | 70771-1681 |
---|---|
NDC 10 | 70771-1681-8 |
NDC Item | 70771168108 |
Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 800438 |
Imprint code | 1035 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
NDC 9 | 76282-701 |
---|---|
NDC 10 | 76282-701-47 |
NDC Item | 76282070147 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
ANDA | ANDA210435 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 655779 |
Imprint code | Cipla25mg;385 |
Labeler | EXELAN PHARMACEUTICALS INC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 76282-701 |
NDC Item 00378194001
NDC 9 | 0378-1940 |
---|---|
NDC 10 | 0378-1940-01 |
NDC Item | 00378194001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
ANDA | ANDA213912 |
COLORTEXT | WHITE(white opaque) |
Color | C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;25 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
NDC 9 | 0378-1940 |
---|---|
NDC 10 | 0378-1940-21 |
NDC Item | 00378194021 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
ANDA | ANDA213912 |
COLORTEXT | WHITE(white opaque) |
Color | C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;25 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
NDC 9 | 0480-1246 |
---|---|
NDC 10 | 0480-1246-21 |
NDC Item | 00480124621 |
Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
ANDA | ANDA201452 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 644159 |
Imprint code | NAT;25mg |
Labeler | Teva Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-03-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
NDC 9 | 31722-262 |
---|---|
NDC 10 | 31722-262-01 |
NDC Item | 31722026201 |
Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
ANDA | ANDA212414 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L7 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
NDC 9 | 31722-262 |
---|---|
NDC 10 | 31722-262-21 |
NDC Item | 31722026221 |
Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
ANDA | ANDA212414 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L7 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
NDC 9 | 43598-515 |
---|---|
NDC 10 | 43598-515-01 |
NDC Item | 43598051501 |
Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
ANDA | ANDA209348 |
COLORTEXT | WHITE(opaque white colored cap and body) |
Color | C48325 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;25;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
NDC 9 | 43598-515 |
---|---|
NDC 10 | 43598-515-21 |
NDC Item | 43598051521 |
Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
ANDA | ANDA209348 |
COLORTEXT | WHITE(opaque white colored cap and body) |
Color | C48325 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;25;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
NDC 9 | 47781-488 |
---|---|
NDC 10 | 47781-488-01 |
NDC Item | 47781048801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
ANDA | ANDA210480 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 789803 |
Imprint code | LP;642 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
NDC 9 | 47781-488 |
---|---|
NDC 10 | 47781-488-77 |
NDC Item | 47781048877 |
Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
ANDA | ANDA210480 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 789803 |
Imprint code | LP;642 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-01 |
NDC Item | 59651034701 |
Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-07 |
NDC Item | 59651034707 |
Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-21 |
NDC Item | 59651034721 |
Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 60505453701
NDC 9 | 60505-4537 |
---|---|
NDC 10 | 60505-4537-1 |
NDC Item | 60505453701 |
Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
Color | C48325;C48325 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L25 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
NDC 9 | 60505-4537 |
---|---|
NDC 10 | 60505-4537-2 |
NDC Item | 60505453702 |
Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
Color | C48325;C48325 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L25 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
NDC 9 | 63304-046 |
---|---|
NDC 10 | 63304-046-01 |
NDC Item | 63304004601 |
Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
ANDA | ANDA211846 |
COLORTEXT | WHITE,WHITE |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;83 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-04 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
NDC 9 | 63304-046 |
---|---|
NDC 10 | 63304-046-22 |
NDC Item | 63304004622 |
Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
ANDA | ANDA211846 |
COLORTEXT | WHITE,WHITE |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;83 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-04 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
NDC 9 | 69097-385 |
---|---|
NDC 10 | 69097-385-81 |
NDC Item | 69097038581 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
ANDA | ANDA210435 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 698711 |
Imprint code | Cipla25mg;385 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 69097-385 |
NDC Item 70710103501
NDC 9 | 70710-1035 |
---|---|
NDC 10 | 70710-1035-1 |
NDC Item | 70710103501 |
Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1035 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
NDC 9 | 70710-1035 |
---|---|
NDC 10 | 70710-1035-8 |
NDC Item | 70710103508 |
Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1035 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
NDC 9 | 70771-1681 |
---|---|
NDC 10 | 70771-1681-1 |
NDC Item | 70771168101 |
Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 800438 |
Imprint code | 1035 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
NDC 9 | 70771-1681 |
---|---|
NDC 10 | 70771-1681-8 |
NDC Item | 70771168108 |
Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 800438 |
Imprint code | 1035 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
NDC 9 | 76282-701 |
---|---|
NDC 10 | 76282-701-47 |
NDC Item | 76282070147 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
ANDA | ANDA210435 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 655779 |
Imprint code | Cipla25mg;385 |
Labeler | EXELAN PHARMACEUTICALS INC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 76282-701 |
NDC Item 00378194001
NDC 9 | 0378-1940 |
---|---|
NDC 10 | 0378-1940-01 |
NDC Item | 00378194001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
ANDA | ANDA213912 |
COLORTEXT | WHITE(white opaque) |
Color | C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;25 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
NDC 9 | 0378-1940 |
---|---|
NDC 10 | 0378-1940-21 |
NDC Item | 00378194021 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
ANDA | ANDA213912 |
COLORTEXT | WHITE(white opaque) |
Color | C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;25 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
NDC 9 | 0480-1246 |
---|---|
NDC 10 | 0480-1246-21 |
NDC Item | 00480124621 |
Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
ANDA | ANDA201452 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 644159 |
Imprint code | NAT;25mg |
Labeler | Teva Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-03-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
NDC 9 | 31722-262 |
---|---|
NDC 10 | 31722-262-01 |
NDC Item | 31722026201 |
Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
ANDA | ANDA212414 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L7 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
NDC 9 | 31722-262 |
---|---|
NDC 10 | 31722-262-21 |
NDC Item | 31722026221 |
Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
ANDA | ANDA212414 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L7 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
NDC 9 | 43598-515 |
---|---|
NDC 10 | 43598-515-01 |
NDC Item | 43598051501 |
Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
ANDA | ANDA209348 |
COLORTEXT | WHITE(opaque white colored cap and body) |
Color | C48325 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;25;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
NDC 9 | 43598-515 |
---|---|
NDC 10 | 43598-515-21 |
NDC Item | 43598051521 |
Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
ANDA | ANDA209348 |
COLORTEXT | WHITE(opaque white colored cap and body) |
Color | C48325 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;25;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
NDC 9 | 47781-488 |
---|---|
NDC 10 | 47781-488-01 |
NDC Item | 47781048801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
ANDA | ANDA210480 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 789803 |
Imprint code | LP;642 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
NDC 9 | 47781-488 |
---|---|
NDC 10 | 47781-488-77 |
NDC Item | 47781048877 |
Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
ANDA | ANDA210480 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 789803 |
Imprint code | LP;642 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-01 |
NDC Item | 59651034701 |
Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-07 |
NDC Item | 59651034707 |
Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-21 |
NDC Item | 59651034721 |
Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 60505453701
NDC 9 | 60505-4537 |
---|---|
NDC 10 | 60505-4537-1 |
NDC Item | 60505453701 |
Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
Color | C48325;C48325 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L25 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
NDC 9 | 60505-4537 |
---|---|
NDC 10 | 60505-4537-2 |
NDC Item | 60505453702 |
Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
Color | C48325;C48325 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L25 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
NDC 9 | 63304-046 |
---|---|
NDC 10 | 63304-046-01 |
NDC Item | 63304004601 |
Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
ANDA | ANDA211846 |
COLORTEXT | WHITE,WHITE |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;83 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-04 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
NDC 9 | 63304-046 |
---|---|
NDC 10 | 63304-046-22 |
NDC Item | 63304004622 |
Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
ANDA | ANDA211846 |
COLORTEXT | WHITE,WHITE |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;83 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-04 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
NDC 9 | 69097-385 |
---|---|
NDC 10 | 69097-385-81 |
NDC Item | 69097038581 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
ANDA | ANDA210435 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 698711 |
Imprint code | Cipla25mg;385 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 69097-385 |
NDC Item 70710103501
NDC 9 | 70710-1035 |
---|---|
NDC 10 | 70710-1035-1 |
NDC Item | 70710103501 |
Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1035 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
NDC 9 | 70710-1035 |
---|---|
NDC 10 | 70710-1035-8 |
NDC Item | 70710103508 |
Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1035 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
NDC 9 | 70771-1681 |
---|---|
NDC 10 | 70771-1681-1 |
NDC Item | 70771168101 |
Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 800438 |
Imprint code | 1035 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
NDC 9 | 70771-1681 |
---|---|
NDC 10 | 70771-1681-8 |
NDC Item | 70771168108 |
Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 800438 |
Imprint code | 1035 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
NDC 9 | 76282-701 |
---|---|
NDC 10 | 76282-701-47 |
NDC Item | 76282070147 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
ANDA | ANDA210435 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 655779 |
Imprint code | Cipla25mg;385 |
Labeler | EXELAN PHARMACEUTICALS INC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 76282-701 |
NDC Item 00378194001
NDC 9 | 0378-1940 |
---|---|
NDC 10 | 0378-1940-01 |
NDC Item | 00378194001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
ANDA | ANDA213912 |
COLORTEXT | WHITE(white opaque) |
Color | C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;25 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
NDC 9 | 0378-1940 |
---|---|
NDC 10 | 0378-1940-21 |
NDC Item | 00378194021 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
ANDA | ANDA213912 |
COLORTEXT | WHITE(white opaque) |
Color | C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;25 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
NDC 9 | 0480-1246 |
---|---|
NDC 10 | 0480-1246-21 |
NDC Item | 00480124621 |
Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
ANDA | ANDA201452 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 644159 |
Imprint code | NAT;25mg |
Labeler | Teva Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-03-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
NDC 9 | 31722-262 |
---|---|
NDC 10 | 31722-262-01 |
NDC Item | 31722026201 |
Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
ANDA | ANDA212414 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L7 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
NDC 9 | 31722-262 |
---|---|
NDC 10 | 31722-262-21 |
NDC Item | 31722026221 |
Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
ANDA | ANDA212414 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L7 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
NDC 9 | 43598-515 |
---|---|
NDC 10 | 43598-515-01 |
NDC Item | 43598051501 |
Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
ANDA | ANDA209348 |
COLORTEXT | WHITE(opaque white colored cap and body) |
Color | C48325 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;25;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
NDC 9 | 43598-515 |
---|---|
NDC 10 | 43598-515-21 |
NDC Item | 43598051521 |
Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
ANDA | ANDA209348 |
COLORTEXT | WHITE(opaque white colored cap and body) |
Color | C48325 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;25;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
NDC 9 | 47781-488 |
---|---|
NDC 10 | 47781-488-01 |
NDC Item | 47781048801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
ANDA | ANDA210480 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 789803 |
Imprint code | LP;642 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
NDC 9 | 47781-488 |
---|---|
NDC 10 | 47781-488-77 |
NDC Item | 47781048877 |
Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
ANDA | ANDA210480 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 789803 |
Imprint code | LP;642 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-01 |
NDC Item | 59651034701 |
Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-07 |
NDC Item | 59651034707 |
Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-21 |
NDC Item | 59651034721 |
Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 60505453701
NDC 9 | 60505-4537 |
---|---|
NDC 10 | 60505-4537-1 |
NDC Item | 60505453701 |
Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
Color | C48325;C48325 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L25 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
NDC 9 | 60505-4537 |
---|---|
NDC 10 | 60505-4537-2 |
NDC Item | 60505453702 |
Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
Color | C48325;C48325 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L25 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
NDC 9 | 63304-046 |
---|---|
NDC 10 | 63304-046-01 |
NDC Item | 63304004601 |
Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
ANDA | ANDA211846 |
COLORTEXT | WHITE,WHITE |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;83 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-04 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
NDC 9 | 63304-046 |
---|---|
NDC 10 | 63304-046-22 |
NDC Item | 63304004622 |
Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
ANDA | ANDA211846 |
COLORTEXT | WHITE,WHITE |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;83 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-04 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
NDC 9 | 69097-385 |
---|---|
NDC 10 | 69097-385-81 |
NDC Item | 69097038581 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
ANDA | ANDA210435 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 698711 |
Imprint code | Cipla25mg;385 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 69097-385 |
NDC Item 70710103501
NDC 9 | 70710-1035 |
---|---|
NDC 10 | 70710-1035-1 |
NDC Item | 70710103501 |
Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1035 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
NDC 9 | 70710-1035 |
---|---|
NDC 10 | 70710-1035-8 |
NDC Item | 70710103508 |
Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1035 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
NDC 9 | 70771-1681 |
---|---|
NDC 10 | 70771-1681-1 |
NDC Item | 70771168101 |
Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 800438 |
Imprint code | 1035 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
NDC 9 | 70771-1681 |
---|---|
NDC 10 | 70771-1681-8 |
NDC Item | 70771168108 |
Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 800438 |
Imprint code | 1035 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
NDC 9 | 76282-701 |
---|---|
NDC 10 | 76282-701-47 |
NDC Item | 76282070147 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
ANDA | ANDA210435 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 655779 |
Imprint code | Cipla25mg;385 |
Labeler | EXELAN PHARMACEUTICALS INC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 76282-701 |
NDC Item 00378194001
NDC 9 | 0378-1940 |
---|---|
NDC 10 | 0378-1940-01 |
NDC Item | 00378194001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
ANDA | ANDA213912 |
COLORTEXT | WHITE(white opaque) |
Color | C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;25 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
NDC 9 | 0378-1940 |
---|---|
NDC 10 | 0378-1940-21 |
NDC Item | 00378194021 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
ANDA | ANDA213912 |
COLORTEXT | WHITE(white opaque) |
Color | C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;25 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
NDC 9 | 0480-1246 |
---|---|
NDC 10 | 0480-1246-21 |
NDC Item | 00480124621 |
Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
ANDA | ANDA201452 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 644159 |
Imprint code | NAT;25mg |
Labeler | Teva Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-03-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
NDC 9 | 31722-262 |
---|---|
NDC 10 | 31722-262-01 |
NDC Item | 31722026201 |
Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
ANDA | ANDA212414 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L7 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
NDC 9 | 31722-262 |
---|---|
NDC 10 | 31722-262-21 |
NDC Item | 31722026221 |
Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
ANDA | ANDA212414 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L7 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
NDC 9 | 43598-515 |
---|---|
NDC 10 | 43598-515-01 |
NDC Item | 43598051501 |
Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
ANDA | ANDA209348 |
COLORTEXT | WHITE(opaque white colored cap and body) |
Color | C48325 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;25;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
NDC 9 | 43598-515 |
---|---|
NDC 10 | 43598-515-21 |
NDC Item | 43598051521 |
Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
ANDA | ANDA209348 |
COLORTEXT | WHITE(opaque white colored cap and body) |
Color | C48325 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;25;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
NDC 9 | 47781-488 |
---|---|
NDC 10 | 47781-488-01 |
NDC Item | 47781048801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
ANDA | ANDA210480 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 789803 |
Imprint code | LP;642 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
NDC 9 | 47781-488 |
---|---|
NDC 10 | 47781-488-77 |
NDC Item | 47781048877 |
Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
ANDA | ANDA210480 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 789803 |
Imprint code | LP;642 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-01 |
NDC Item | 59651034701 |
Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-07 |
NDC Item | 59651034707 |
Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-21 |
NDC Item | 59651034721 |
Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 60505453701
NDC 9 | 60505-4537 |
---|---|
NDC 10 | 60505-4537-1 |
NDC Item | 60505453701 |
Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
Color | C48325;C48325 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L25 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
NDC 9 | 60505-4537 |
---|---|
NDC 10 | 60505-4537-2 |
NDC Item | 60505453702 |
Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
Color | C48325;C48325 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L25 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
NDC 9 | 63304-046 |
---|---|
NDC 10 | 63304-046-01 |
NDC Item | 63304004601 |
Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
ANDA | ANDA211846 |
COLORTEXT | WHITE,WHITE |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;83 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-04 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
NDC 9 | 63304-046 |
---|---|
NDC 10 | 63304-046-22 |
NDC Item | 63304004622 |
Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
ANDA | ANDA211846 |
COLORTEXT | WHITE,WHITE |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;83 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-04 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
NDC 9 | 69097-385 |
---|---|
NDC 10 | 69097-385-81 |
NDC Item | 69097038581 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
ANDA | ANDA210435 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 698711 |
Imprint code | Cipla25mg;385 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 69097-385 |
NDC Item 70710103501
NDC 9 | 70710-1035 |
---|---|
NDC 10 | 70710-1035-1 |
NDC Item | 70710103501 |
Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1035 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
NDC 9 | 70710-1035 |
---|---|
NDC 10 | 70710-1035-8 |
NDC Item | 70710103508 |
Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1035 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
NDC 9 | 70771-1681 |
---|---|
NDC 10 | 70771-1681-1 |
NDC Item | 70771168101 |
Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 800438 |
Imprint code | 1035 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
NDC 9 | 70771-1681 |
---|---|
NDC 10 | 70771-1681-8 |
NDC Item | 70771168108 |
Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 800438 |
Imprint code | 1035 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
NDC 9 | 76282-701 |
---|---|
NDC 10 | 76282-701-47 |
NDC Item | 76282070147 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
ANDA | ANDA210435 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 655779 |
Imprint code | Cipla25mg;385 |
Labeler | EXELAN PHARMACEUTICALS INC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 76282-701 |
NDC Item 00378194001
NDC 9 | 0378-1940 |
---|---|
NDC 10 | 0378-1940-01 |
NDC Item | 00378194001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
ANDA | ANDA213912 |
COLORTEXT | WHITE(white opaque) |
Color | C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;25 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
NDC 9 | 0378-1940 |
---|---|
NDC 10 | 0378-1940-21 |
NDC Item | 00378194021 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
ANDA | ANDA213912 |
COLORTEXT | WHITE(white opaque) |
Color | C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;25 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
NDC 9 | 0480-1246 |
---|---|
NDC 10 | 0480-1246-21 |
NDC Item | 00480124621 |
Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
ANDA | ANDA201452 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 644159 |
Imprint code | NAT;25mg |
Labeler | Teva Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-03-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
NDC 9 | 31722-262 |
---|---|
NDC 10 | 31722-262-01 |
NDC Item | 31722026201 |
Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
ANDA | ANDA212414 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L7 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
NDC 9 | 31722-262 |
---|---|
NDC 10 | 31722-262-21 |
NDC Item | 31722026221 |
Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
ANDA | ANDA212414 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L7 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
NDC 9 | 43598-515 |
---|---|
NDC 10 | 43598-515-01 |
NDC Item | 43598051501 |
Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
ANDA | ANDA209348 |
COLORTEXT | WHITE(opaque white colored cap and body) |
Color | C48325 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;25;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
NDC 9 | 43598-515 |
---|---|
NDC 10 | 43598-515-21 |
NDC Item | 43598051521 |
Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
ANDA | ANDA209348 |
COLORTEXT | WHITE(opaque white colored cap and body) |
Color | C48325 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;25;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
NDC 9 | 47781-488 |
---|---|
NDC 10 | 47781-488-01 |
NDC Item | 47781048801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
ANDA | ANDA210480 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 789803 |
Imprint code | LP;642 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
NDC 9 | 47781-488 |
---|---|
NDC 10 | 47781-488-77 |
NDC Item | 47781048877 |
Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
ANDA | ANDA210480 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 789803 |
Imprint code | LP;642 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-01 |
NDC Item | 59651034701 |
Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-07 |
NDC Item | 59651034707 |
Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-21 |
NDC Item | 59651034721 |
Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 60505453701
NDC 9 | 60505-4537 |
---|---|
NDC 10 | 60505-4537-1 |
NDC Item | 60505453701 |
Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
Color | C48325;C48325 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L25 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
NDC 9 | 60505-4537 |
---|---|
NDC 10 | 60505-4537-2 |
NDC Item | 60505453702 |
Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
Color | C48325;C48325 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L25 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
NDC 9 | 63304-046 |
---|---|
NDC 10 | 63304-046-01 |
NDC Item | 63304004601 |
Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
ANDA | ANDA211846 |
COLORTEXT | WHITE,WHITE |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;83 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-04 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
NDC 9 | 63304-046 |
---|---|
NDC 10 | 63304-046-22 |
NDC Item | 63304004622 |
Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
ANDA | ANDA211846 |
COLORTEXT | WHITE,WHITE |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;83 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-04 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
NDC 9 | 69097-385 |
---|---|
NDC 10 | 69097-385-81 |
NDC Item | 69097038581 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
ANDA | ANDA210435 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 698711 |
Imprint code | Cipla25mg;385 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 69097-385 |
NDC Item 70710103501
NDC 9 | 70710-1035 |
---|---|
NDC 10 | 70710-1035-1 |
NDC Item | 70710103501 |
Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1035 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
NDC 9 | 70710-1035 |
---|---|
NDC 10 | 70710-1035-8 |
NDC Item | 70710103508 |
Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1035 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
NDC 9 | 70771-1681 |
---|---|
NDC 10 | 70771-1681-1 |
NDC Item | 70771168101 |
Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 800438 |
Imprint code | 1035 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
NDC 9 | 70771-1681 |
---|---|
NDC 10 | 70771-1681-8 |
NDC Item | 70771168108 |
Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 800438 |
Imprint code | 1035 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
NDC 9 | 76282-701 |
---|---|
NDC 10 | 76282-701-47 |
NDC Item | 76282070147 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
ANDA | ANDA210435 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 655779 |
Imprint code | Cipla25mg;385 |
Labeler | EXELAN PHARMACEUTICALS INC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 76282-701 |
NDC Item 00378194001
NDC 9 | 0378-1940 |
---|---|
NDC 10 | 0378-1940-01 |
NDC Item | 00378194001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
ANDA | ANDA213912 |
COLORTEXT | WHITE(white opaque) |
Color | C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;25 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
NDC 9 | 0378-1940 |
---|---|
NDC 10 | 0378-1940-21 |
NDC Item | 00378194021 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
ANDA | ANDA213912 |
COLORTEXT | WHITE(white opaque) |
Color | C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;25 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
NDC 9 | 0480-1246 |
---|---|
NDC 10 | 0480-1246-21 |
NDC Item | 00480124621 |
Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
ANDA | ANDA201452 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 644159 |
Imprint code | NAT;25mg |
Labeler | Teva Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-03-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
NDC 9 | 31722-262 |
---|---|
NDC 10 | 31722-262-01 |
NDC Item | 31722026201 |
Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
ANDA | ANDA212414 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L7 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
NDC 9 | 31722-262 |
---|---|
NDC 10 | 31722-262-21 |
NDC Item | 31722026221 |
Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
ANDA | ANDA212414 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L7 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
NDC 9 | 43598-515 |
---|---|
NDC 10 | 43598-515-01 |
NDC Item | 43598051501 |
Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
ANDA | ANDA209348 |
COLORTEXT | WHITE(opaque white colored cap and body) |
Color | C48325 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;25;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
NDC 9 | 43598-515 |
---|---|
NDC 10 | 43598-515-21 |
NDC Item | 43598051521 |
Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
ANDA | ANDA209348 |
COLORTEXT | WHITE(opaque white colored cap and body) |
Color | C48325 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;25;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
NDC 9 | 47781-488 |
---|---|
NDC 10 | 47781-488-01 |
NDC Item | 47781048801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
ANDA | ANDA210480 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 789803 |
Imprint code | LP;642 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
NDC 9 | 47781-488 |
---|---|
NDC 10 | 47781-488-77 |
NDC Item | 47781048877 |
Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
ANDA | ANDA210480 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 789803 |
Imprint code | LP;642 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-01 |
NDC Item | 59651034701 |
Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-07 |
NDC Item | 59651034707 |
Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-21 |
NDC Item | 59651034721 |
Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 60505453701
NDC 9 | 60505-4537 |
---|---|
NDC 10 | 60505-4537-1 |
NDC Item | 60505453701 |
Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
Color | C48325;C48325 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L25 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
NDC 9 | 60505-4537 |
---|---|
NDC 10 | 60505-4537-2 |
NDC Item | 60505453702 |
Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
Color | C48325;C48325 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L25 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
NDC 9 | 63304-046 |
---|---|
NDC 10 | 63304-046-01 |
NDC Item | 63304004601 |
Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
ANDA | ANDA211846 |
COLORTEXT | WHITE,WHITE |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;83 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-04 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
NDC 9 | 63304-046 |
---|---|
NDC 10 | 63304-046-22 |
NDC Item | 63304004622 |
Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
ANDA | ANDA211846 |
COLORTEXT | WHITE,WHITE |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;83 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-04 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
NDC 9 | 69097-385 |
---|---|
NDC 10 | 69097-385-81 |
NDC Item | 69097038581 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
ANDA | ANDA210435 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 698711 |
Imprint code | Cipla25mg;385 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 69097-385 |
NDC Item 70710103501
NDC 9 | 70710-1035 |
---|---|
NDC 10 | 70710-1035-1 |
NDC Item | 70710103501 |
Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1035 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
NDC 9 | 70710-1035 |
---|---|
NDC 10 | 70710-1035-8 |
NDC Item | 70710103508 |
Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1035 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
NDC 9 | 70771-1681 |
---|---|
NDC 10 | 70771-1681-1 |
NDC Item | 70771168101 |
Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 800438 |
Imprint code | 1035 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
NDC 9 | 70771-1681 |
---|---|
NDC 10 | 70771-1681-8 |
NDC Item | 70771168108 |
Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 800438 |
Imprint code | 1035 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
NDC 9 | 76282-701 |
---|---|
NDC 10 | 76282-701-47 |
NDC Item | 76282070147 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
ANDA | ANDA210435 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 655779 |
Imprint code | Cipla25mg;385 |
Labeler | EXELAN PHARMACEUTICALS INC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 76282-701 |
NDC Item 00378194001
NDC 9 | 0378-1940 |
---|---|
NDC 10 | 0378-1940-01 |
NDC Item | 00378194001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
ANDA | ANDA213912 |
COLORTEXT | WHITE(white opaque) |
Color | C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;25 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
NDC 9 | 0378-1940 |
---|---|
NDC 10 | 0378-1940-21 |
NDC Item | 00378194021 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
ANDA | ANDA213912 |
COLORTEXT | WHITE(white opaque) |
Color | C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;25 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
NDC 9 | 0480-1246 |
---|---|
NDC 10 | 0480-1246-21 |
NDC Item | 00480124621 |
Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
ANDA | ANDA201452 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 644159 |
Imprint code | NAT;25mg |
Labeler | Teva Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-03-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
NDC 9 | 31722-262 |
---|---|
NDC 10 | 31722-262-01 |
NDC Item | 31722026201 |
Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
ANDA | ANDA212414 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L7 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
NDC 9 | 31722-262 |
---|---|
NDC 10 | 31722-262-21 |
NDC Item | 31722026221 |
Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
ANDA | ANDA212414 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L7 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
NDC 9 | 43598-515 |
---|---|
NDC 10 | 43598-515-01 |
NDC Item | 43598051501 |
Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
ANDA | ANDA209348 |
COLORTEXT | WHITE(opaque white colored cap and body) |
Color | C48325 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;25;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
NDC 9 | 43598-515 |
---|---|
NDC 10 | 43598-515-21 |
NDC Item | 43598051521 |
Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
ANDA | ANDA209348 |
COLORTEXT | WHITE(opaque white colored cap and body) |
Color | C48325 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;25;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
NDC 9 | 47781-488 |
---|---|
NDC 10 | 47781-488-01 |
NDC Item | 47781048801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
ANDA | ANDA210480 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 789803 |
Imprint code | LP;642 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
NDC 9 | 47781-488 |
---|---|
NDC 10 | 47781-488-77 |
NDC Item | 47781048877 |
Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
ANDA | ANDA210480 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 789803 |
Imprint code | LP;642 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-01 |
NDC Item | 59651034701 |
Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-07 |
NDC Item | 59651034707 |
Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
NDC 9 | 59651-347 |
---|---|
NDC 10 | 59651-347-21 |
NDC Item | 59651034721 |
Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;25 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 59651-347 |
NDC Item 60505453701
NDC 9 | 60505-4537 |
---|---|
NDC 10 | 60505-4537-1 |
NDC Item | 60505453701 |
Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
Color | C48325;C48325 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L25 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
NDC 9 | 60505-4537 |
---|---|
NDC 10 | 60505-4537-2 |
NDC Item | 60505453702 |
Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
Color | C48325;C48325 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L25 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
NDC 9 | 63304-046 |
---|---|
NDC 10 | 63304-046-01 |
NDC Item | 63304004601 |
Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
ANDA | ANDA211846 |
COLORTEXT | WHITE,WHITE |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;83 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-04 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
NDC 9 | 63304-046 |
---|---|
NDC 10 | 63304-046-22 |
NDC Item | 63304004622 |
Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
ANDA | ANDA211846 |
COLORTEXT | WHITE,WHITE |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;83 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-04 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
NDC 9 | 69097-385 |
---|---|
NDC 10 | 69097-385-81 |
NDC Item | 69097038581 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
ANDA | ANDA210435 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 698711 |
Imprint code | Cipla25mg;385 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 69097-385 |
NDC Item 70710103501
NDC 9 | 70710-1035 |
---|---|
NDC 10 | 70710-1035-1 |
NDC Item | 70710103501 |
Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1035 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
NDC 9 | 70710-1035 |
---|---|
NDC 10 | 70710-1035-8 |
NDC Item | 70710103508 |
Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1035 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
NDC 9 | 70771-1681 |
---|---|
NDC 10 | 70771-1681-1 |
NDC Item | 70771168101 |
Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 800438 |
Imprint code | 1035 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
NDC 9 | 70771-1681 |
---|---|
NDC 10 | 70771-1681-8 |
NDC Item | 70771168108 |
Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 800438 |
Imprint code | 1035 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
NDC 9 | 76282-701 |
---|---|
NDC 10 | 76282-701-47 |
NDC Item | 76282070147 |
Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
ANDA | ANDA210435 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 655779 |
Imprint code | Cipla25mg;385 |
Labeler | EXELAN PHARMACEUTICALS INC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 76282-701 |